Skip to content

Category: Science Medical

Getting to the facts on specialist fees and clearing up the confusion, from those that create it.

By API User

Anaesthetists in Australia provide over 2.6 million episodes of care each year, delivering individualised, high-quality, and safety-driven services that enable patients to undergo surgery, interventional procedures, childbirth, trauma management and complex pain treatments. This care is provided under some of the most rigorous regulatory, professional, and training standards internationally. ASA President Dr Vida Viliunas said … Continued

Patch offers hope to save frog populations

By API User

La Trobe University academics have developed a non-invasive way to monitor hormones in frogs in an important step towards protecting the vulnerable animals from extinction.  Global frog populations are disappearing at an alarming rate due to issues such as habitat loss, climate change, pollution, invasive species and disease, with 41 per cent of species listed … Continued

Australian scientists reveal new genetic risk for severe macular degeneration

By API User

Researchers and a person living with macular degeneration are available for interview in East Melbourne today.   Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD). A new study, published today in Nature Communications, reveals the specific genetic factors linked to … Continued

SoluPet Inc. (SoluPet) Announces Strategic Partnership with CHC Healthcare Group (CHC) to Advance Canine Cognitive Health in Asia

By API User

Partnership with CHC in Taiwan will pilot SoluPet’s flagship Neuronal Defense™ formulation through CHC’s veterinary and consumer-health ecosystem TORONTO–BUSINESS WIRE– SoluPet,the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs, today announced a strategic partnership with CHC, one of Asia’s largest publicly traded healthcare organizations. CHC – with more than … Continued

AdvanCell Receives First Delivery of High-Activity Thorium-228, Highlighting a Unique Industry Capability and Expertise Essential to Scaling Lead-212 Production for Targeted Alpha Therapies

By API User

Thorium-228 (228Th) is the parent isotope and key starting material to produce the alpha-emitter Lead-212 (212Pb) The established capability to receive and process high-activity 228Th, provides a key competitive advantage in scaling up 212Pb production to support the rapid advancement of 212Pb-ADVC001 (ADVC001) clinical development and the expanding pipeline The received 228Th will be processed … Continued

BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia

By API User

Multiple long-term follow-up studies confirm BRUKINSA’s superior efficacy and favorable tolerability versus ibrutinib in relapsed or refractory CLL Additional ASH data from investigational BTK degrader, BGB-16673, highlight potential first- and best-in-class activity with durable responses in heavily pretreated patients with CLL SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a … Continued

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

By API User

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12) After 12 weeks off therapy (week 25 of the study), 82% of evaluable patients (9 of 11) maintained a durable reduction in total polyp burden, … Continued

IBMI SNQ and ICHOM Forms Strategic Partnership in Asia, Advancing Patient-centered Healthcare in the Region

By API User

TAIPEI, Taiwan–BUSINESS WIRE– The Symbol of National Quality (SNQ), initiated by Taiwan’s Institute for Biotechnology and Medicine Industry (IBMI), has partnered with the International Consortium for Health Outcomes Measurement (ICHOM) to set a new benchmark for healthcare standards across the Asia-Pacific region. The partnership agreement, signed by Chen Wei-Jao, Chief Convener, SNQ Committee, and Jennifer … Continued

Galderma Welcomes Increased Equity Investment From L’Oréal

By API User

L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–BUSINESS WIRE– Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an … Continued

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

By API User

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on … Continued